The feasibility, safety, and efficacy of lower limb garment-integrated blood flow restriction training in healthy adults.
Blood flow restriction
Feasibility
Kaatsu training
Occlusion training
Safety
Journal
Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine
ISSN: 1873-1600
Titre abrégé: Phys Ther Sport
Pays: England
ID NLM: 100940513
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
28
09
2022
revised:
06
01
2023
accepted:
07
01
2023
pubmed:
15
1
2023
medline:
3
3
2023
entrez:
14
1
2023
Statut:
ppublish
Résumé
Explore the feasibility of lower-limb garment-integrated BFR-training. Observational study. Human performance laboratory. Healthy males with no experience of BFR-training. Feasibility was determined by a priori thresholds for recruitment, adherence, and data collection. Safety was determined by measuring BFR torniquet pressure and the incidence of side effects. Efficacy was determined by measuring body anthropometry and knee isokinetic dynamometry. Feasibility and safety outcomes were reported descriptively or as a proportion with 95% confidence intervals (95% CI), with mean change, 95% CIs, and effect sizes for efficacy outcomes. Twelve participants (mean age 24.8 years [6.5]) were successfully recruited; 11 completed the study. 134/136 sessions were completed (adherence = 98.5%) and 100% of data were collected. There was one event of excessive pain during exercise (0.7%, 95% CI 0.0%, 4.0%), two events of excessive pain post-exercise (1.5%, 95% CI 0.4%, 5.5%), and one event of persistent paraesthesia post-exercise (0.7%, 95% CI 0.0%, 4.0%). Mean maximal BFR torniquet pressure was <200 mmHg. We observed an increase in knee extension peak torque (mean change 12.4 Nm), but no notable changes in body anthropometry. Lower-limb garment-integrated BFR-training is feasible, has no signal of important harm, and could be used independently.
Identifiants
pubmed: 36640641
pii: S1466-853X(23)00006-8
doi: 10.1016/j.ptsp.2023.01.006
pii:
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-16Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Dr Warren J. Bradley is the chief technical officer of Hytro Ltd. All other authors have no competing interests to declare.